ArticleBioengineering & translational medicine2025
Early nanoparticle intervention preserves motor function following cervical spinal cord injury.
Article in Bioengineering & translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Nanoparticle and epothilone D combinatorial intervention improves motor performance and regeneration in chronic cervical spinal cord injury.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025Article
- Early nanoparticle intervention preserves motor function following cervical spinal cord injury.Bioengineering & translational medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Spinal cord injury (SCI) triggers an immediate influx of immune cells that secrete pro-inflammatory cytokines and reactive oxygen species that cause tissue damage that is secondary to the initial physical trauma. We aim to reprogram these immune cells to promote a less inflammatory and more pro-regenerative environment. Herein, we investigated the window in time during which poly(lactide-co-glycolide) nanoparticles (NPs) administration can successfully modulate the immune response and promote functional sparing. The dynamics of immune cell infiltration and secondary tissue damage were studied following the injection of NPs intravenously every 24 h for 7 days following injury, with the first injection starting at 2, 4, or 24 hours post-injury (hpi). At 7 days post-injury (dpi), early NP intervention decreased the number of infiltrating macrophages and neutrophils, but delaying treatment until 24 hpi increased the number of neutrophils above control. All mice that received NPs had greater neuronal sparing contralateral to the injury, but mice that received NPs at early timepoints had greater neuromuscular junction innervation and motor endplate sparing. The increased sparing of neurons and neural circuits in the 2 hpi NP group corresponded with increased motor function, as measured by a ladder beam test. Collectively, these results suggest that early intervention with NPs can modulate the inflammatory response and preserve motor function and circuits following SCI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.